Trial intelligence / Profile preview

Finacea Gel 15% in Mild to Moderate Acne

NCT00031096Phase 3Completed

Sponsor
LEO Pharma
Start
Jan 2002
Primary completion
Jul 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Azelaic acid in acne vulgaris, sponsored by LEO Pharma. Started Jan 2002; status: completed.

02

Drugs

Azelaic acid
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00031096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00031096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call